Skip to main content
. 2016 Aug 10;3:16019. doi: 10.1038/mto.2016.19

Figure 5.

Figure 5

Effect of a Janus kinase inhibitor on mumps virus infectivity. Selected tumor cells lines were treated with Ruxolitinib, a Janus kinase inhibitor, at the indicated doses. After 48 hours the treated and controlled cells were infected with rMuV-UC-GFP mumps virus (multiplicity of infection (MOI,. 10). Fluorescent images were taken 5 days postinfection. GFP, green fluorescent protein.